XML 61 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Operating Activities:      
Net loss $ (26,417)us-gaap_NetIncomeLoss $ (26,624)us-gaap_NetIncomeLoss $ (22,264)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 549us-gaap_DepreciationDepletionAndAmortization 569us-gaap_DepreciationDepletionAndAmortization 660us-gaap_DepreciationDepletionAndAmortization
Amortization of premium on marketable securities 1,098us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments 912us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments 889us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments
Stock-based compensation 9,200us-gaap_ShareBasedCompensation 6,146us-gaap_ShareBasedCompensation 5,338us-gaap_ShareBasedCompensation
Net loss on disposal of property and equipment     123us-gaap_GainLossOnSaleOfPropertyPlantEquipment
Change in fair value of contingent consideration liability 230us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 60us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1  
Net changes in operating assets and liabilities:      
Restricted cash   (320)us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities  
Escrow liability   275sgmo_IncreaseDecreaseInEscrowLiabilities  
Interest receivable (85)us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet (148)us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet 141us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet
Accounts receivable (7,213)us-gaap_IncreaseDecreaseInAccountsReceivable 1,008us-gaap_IncreaseDecreaseInAccountsReceivable (3,414)us-gaap_IncreaseDecreaseInAccountsReceivable
Prepaid expenses and other assets (258)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (160)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets 14us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Accounts payable and accrued liabilities 4,324us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 269us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities (1,503)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Accrued compensation and employee benefits (341)us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities 721us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities 800us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities
Deferred revenues 13,238us-gaap_IncreaseDecreaseInDeferredRevenue (2,190)us-gaap_IncreaseDecreaseInDeferredRevenue 11,134us-gaap_IncreaseDecreaseInDeferredRevenue
Net cash used in operating activities (5,675)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (19,482)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (8,082)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Investing Activities:      
Purchases of marketable securities (227,802)us-gaap_PaymentsToAcquireMarketableSecurities (118,894)us-gaap_PaymentsToAcquireMarketableSecurities (91,428)us-gaap_PaymentsToAcquireMarketableSecurities
Maturities of marketable securities 127,765us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities 51,129us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities 103,470us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities
Acquistion of Ceregene, Inc., net of cash received   79us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired  
Purchases of property and equipment (621)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (432)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (723)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Net cash provided by / (used in) investing activities (100,658)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (68,118)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations 11,319us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Financing Activities:      
Proceeds from public offering of common stock, net of issuance costs 93,796sgmo_NetProceedsFromIssuancePublicOffering 69,492sgmo_NetProceedsFromIssuancePublicOffering  
Taxes paid related to net share settlement of equity awards (4,556)us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation (2,015)us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation  
Proceeds from issuance of common stock 12,937us-gaap_ProceedsFromIssuanceOfCommonStock 8,630us-gaap_ProceedsFromIssuanceOfCommonStock 1,676us-gaap_ProceedsFromIssuanceOfCommonStock
Net cash provided by financing activities 102,177us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 76,107us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 1,676us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net increase / (decrease) in cash and cash equivalents (4,156)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (11,493)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 4,913us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of period 10,186us-gaap_CashAndCashEquivalentsAtCarryingValue 21,679us-gaap_CashAndCashEquivalentsAtCarryingValue 16,766us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of period 6,030us-gaap_CashAndCashEquivalentsAtCarryingValue 10,186us-gaap_CashAndCashEquivalentsAtCarryingValue 21,679us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosure of noncash investing activities:      
Fair value of shares of common stock issued pursuant to the acquisition of Ceregene Inc.   $ 1,200sgmo_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueOfCommonStockIssued